• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX FX OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX FX OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Catalog Number CX*FX25RW
Device Problem Tear, Rip or Hole in Device Packaging (2385)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/06/2018
Event Type  malfunction  
Manufacturer Narrative
Implanted date: device was not implanted.Explanted date: device was not explanted.510(k)- k130520.The actual device was returned for evaluation.Visual inspection upon receipt of the actual sample, before taking it out of the unit box, found the individual tyvek pack had some scuffs on its surface.The actual sample was taken out of the unit box for further inspection.It was found that the tyvek magnifying inspection of the scuffs found that they had not been developed into the holes reported by the customer.The thickness of the tyvek pack was measured and confirmed to be equivalent to that of the factory-retained sample.Visual inspection of the original unit-box and cushion material found that they had been deformed.It is unknown when and how they got the damage.A review of the manufacturing record and shipping inspection record of the involved product/lot# combination was conducted with no relevant findings.Ifu reference: inspect the device and package carefully.Do not use if the package and/or device is damaged.There is no evidence that this event was related to a device defect or malfunction.It is likely that the actual sample came into excessive contact with the product packed in it and the cushion material due to intensive shock force the actual sample was exposed to during transportation or during being handled by the customer, resulting in the generation of the scuff on the tyvek pack.(b)(4).
 
Event Description
The user facility reported when the perfusionist was preparing stocks the capiox oxygenator plastic packaging got holes.The holes compromised the sterility of the oxygenator.The event occurred pre-treatment and the patient was not harmed.The procedure outcome was unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX FX OXYGENATOR
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA   418
Manufacturer Contact
terry callahan
reg. no. 2243441
2101 cottontail ln.
somerset, NJ 08873
8002837866
MDR Report Key7645810
MDR Text Key112872186
Report Number9681834-2018-00113
Device Sequence Number1
Product Code DTZ
UDI-Device Identifier04987350701046
UDI-Public04987350701046
Combination Product (y/n)N
Reporter Country CodeSN
PMA/PMN Number
K071494
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial
Report Date 06/28/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/28/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2020
Device Catalogue NumberCX*FX25RW
Device Lot Number171110
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/18/2018
Was the Report Sent to FDA? No
Date Manufacturer Received06/08/2018
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-